The device was not returned for analysis.A review of the lot history record revealed no manufacturing nonconformities issued to the reported lot that would have contributed to this event.Based on available information, the cause of the reported perforation was unable to be determined.The reported patient effect of perforation, as listed in the mitraclip system instructions for use, is a known possible complication associated with mitraclip procedures.The reported unexpected medical intervention was a result of case-specific circumstances.There is no indication of a product quality issue with respect to manufacture, design, or labeling.The additional mitraclip device referenced in b5 is being filed under a separate medwatch report.
|
It was reported a mitraclip procedure was performed to treat functional mitral regurgitation (mr) and tricuspid regurgitation (tr) with a grade of 5+.A steerable guide catheter (sgc) was inserted and three clips were successfully deployed on the mitral valve without issues.The sgc was then retracted into the right atrium (ra) and one mitraclip was deployed on the tricuspid valve.However, after deployment, it was suspected the clip detached from the anterior leaflet and remained attached to the septal leaflet (single leaflet device attachment/slda).Tr was reduced to a grade of 3-4 and no additional treatment was performed.After removal of the sgc, a left to right shunt was observed.Therefore, an atrial sept defect (asd) closure device was implanted.No clinically significant delay in the procedure.
|